Terig Hughes
Direttore Finanziario/CFO presso VOLITIONRX LIMITED
Patrimonio netto: 294 213 $ in data 30/04/2024
Posizioni attive di Terig Hughes
Società | Posizione | Inizio | Fine |
---|---|---|---|
VOLITIONRX LIMITED | Direttore Finanziario/CFO | 01/02/2021 | - |
Treasurer | 01/02/2021 | - | |
Singapore Volition Pte Ltd.
Singapore Volition Pte Ltd. Hospital/Nursing ManagementHealth Services Part of VolitionRX Ltd., Singapore Volition Pte Ltd. provides diagnostic services for cancer patients. Singapore Volition was acquired by Standard Capital Corp. on October 07, 2011 for $0.07 million. | Direttore/Membro del Consiglio | 01/09/2021 | - |
Volition Global Services SRL | Direttore/Membro del Consiglio | 01/09/2021 | - |
Storia della carriera di Terig Hughes
Precedenti posizioni note di Terig Hughes
Società | Posizione | Inizio | Fine |
---|---|---|---|
AUM Biosciences Pte Ltd.
AUM Biosciences Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AUM Biosciences Ltd., AUM Biosciences Pte Ltd. is a clinical-stage biotech company based in Singapore, Singapore. The Singaporean company focuses on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. AUM Biosciences has an extensive track record of selecting distinctive early-stage assets, successfully exiting virtual biotech models, and contributing significantly to the development of several currently marketed oncology treatments with annual peak sales up to $3 billion. AUM Biosciences is advancing a broad portfolio of precision oncology therapeutics, including AUM001, AUM601, and AUM302, which have entered clinical trials and received orphan drug designation from the FDA for the treatment of various cancers. The company was founded by Harish Dave and is currently led by CEO Vishal Doshi. | Direttore Finanziario/CFO | 01/01/2018 | 01/01/2020 |
RELX Group Plc
RELX Group Plc Packaged SoftwareTechnology Services RELX Group Plc engages in the provision of information and analytics for professional and business customers. It operates in four major segments such as scientific, technical and medical, risk and business analytics, legal and exhibitions. The company was founded on September 11, 1992 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/01/2014 | 01/01/2017 |
Elsevier, Inc.
Elsevier, Inc. Publishing: Books/MagazinesConsumer Services Elsevier, Inc. publishes journals, online materials, and books. It offers Scopus, ScienceDirect, Mendeley, Evolve, Knovel, Reaxys and ClinicalKey. The company is headquartered in Newton, MA. | Corporate Officer/Principal | 01/01/2003 | 01/01/2006 |
Formazione di Terig Hughes
De Montfort University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Regno Unito | 3 |
Singapore | 3 |
Posizioni
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Settori
Consumer Services | 3 |
Technology Services | 2 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
VOLITIONRX LIMITED | Health Technology |
Aziende private | 5 |
---|---|
Elsevier, Inc.
Elsevier, Inc. Publishing: Books/MagazinesConsumer Services Elsevier, Inc. publishes journals, online materials, and books. It offers Scopus, ScienceDirect, Mendeley, Evolve, Knovel, Reaxys and ClinicalKey. The company is headquartered in Newton, MA. | Consumer Services |
RELX Group Plc
RELX Group Plc Packaged SoftwareTechnology Services RELX Group Plc engages in the provision of information and analytics for professional and business customers. It operates in four major segments such as scientific, technical and medical, risk and business analytics, legal and exhibitions. The company was founded on September 11, 1992 and is headquartered in London, the United Kingdom. | Technology Services |
Singapore Volition Pte Ltd.
Singapore Volition Pte Ltd. Hospital/Nursing ManagementHealth Services Part of VolitionRX Ltd., Singapore Volition Pte Ltd. provides diagnostic services for cancer patients. Singapore Volition was acquired by Standard Capital Corp. on October 07, 2011 for $0.07 million. | Health Services |
AUM Biosciences Pte Ltd.
AUM Biosciences Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AUM Biosciences Ltd., AUM Biosciences Pte Ltd. is a clinical-stage biotech company based in Singapore, Singapore. The Singaporean company focuses on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. AUM Biosciences has an extensive track record of selecting distinctive early-stage assets, successfully exiting virtual biotech models, and contributing significantly to the development of several currently marketed oncology treatments with annual peak sales up to $3 billion. AUM Biosciences is advancing a broad portfolio of precision oncology therapeutics, including AUM001, AUM601, and AUM302, which have entered clinical trials and received orphan drug designation from the FDA for the treatment of various cancers. The company was founded by Harish Dave and is currently led by CEO Vishal Doshi. | Commercial Services |
Volition Global Services SRL |
- Borsa valori
- Insiders
- Terig Hughes
- Esperienza